About NECA
NECA, a public agency devoted to the improvement of national health and future of healthcareWhat we do
NECA, a public agency devoted to the improvement of national health and future of healthcarePublication
NECA, a public agency devoted to the improvement of national health and future of healthcareInternational Cooperation
NECA, a public agency devoted to the improvement of national health and future of healthcareNECA GRADE Center
NECA, a public agency devoted to the improvement of national health and future of healthcareSUBJECT |
PUBLISH
Cost-effectiveness of conventional cytology and HPV DNA testing for cervical cancer screening in South Korea |
---|---|
PUBLISH DATE | 2014.04.21 |
FILE |
![]() |
National Cervical Screening Programme in Korea recommends that a biannual cervical pap smear test interval is appropriate for women over 30 years. Conventional cytology is relatively simple and cheap method of cervical cancer screening and eventually has reduced the cervical cancer incidence and mortality. However, several studies in abroad have shown the relatively high false negative rate and reported that HPV testing is more sensitive than cytology. The recent updated guidelines from Korean Society of Gynecology Oncology and Korean Society of Pathologists in 2012 recommends that annual pap smear test in the age group 20~29 years and biannual screening of pap smear and HPV test in the age group 30~70 years. Although the most accurate or cost-effective cervical cancer screening methods is different in each country, there is a paucity of evaluative research in Korea. Therefore this study aims to suggest the evidence for guidelines of cervical cancer screening by comparing accuracy of cervical cancer test methods and performing cost-effectiveness analysis. |
Journal Publication |
|
---|
Creative Commons License ![]() |
Korea Open Government License ![]() · NC · SA |
Contact Us Report & Quote. - Report : +82-2-2174-2883 - Quote : +82-2-2174-2787 |
Prev | Comparative effectiveness of medication therapies in the rheumatoid arthritis patients |
---|---|
Next | Introduction of horizon scanning system for emerging health technologies |